.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Julphar
Dow
Argus Health
AstraZeneca
Moodys
UBS
Medtronic
Mallinckrodt
Cipla

Generated: November 19, 2017

DrugPatentWatch Database Preview

Norton Waterford Company Profile

« Back to Dashboard

What is the competitive landscape for NORTON WATERFORD, and when can generic versions of NORTON WATERFORD drugs launch?

NORTON WATERFORD has one approved drug.

There are four US patents protecting NORTON WATERFORD drugs.

There are sixty-nine patent family members on NORTON WATERFORD drugs in twenty-six countries.

Summary for Norton Waterford

International Patents:69
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-001Aug 3, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-001Aug 3, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-002Aug 3, 2017RXYesYes► Subscribe► SubscribeY ► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-002Aug 3, 2017RXYesYes► Subscribe► SubscribeY ► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-002Aug 3, 2017RXYesYes► Subscribe► SubscribeY ► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-001Aug 3, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-001Aug 3, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-002Aug 3, 2017RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Norton Waterford

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,553,988 Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber► Subscribe
8,225,780Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Norton Waterford Drugs

Country Document Number Estimated Expiration
United Kingdom0706999► Subscribe
Portugal2440271► Subscribe
Denmark2440271► Subscribe
Mexico2009010600► Subscribe
Canada2682528► Subscribe
Hong Kong1201766► Subscribe
Cyprus1115810► Subscribe
Eurasian Patent Organization016831► Subscribe
World Intellectual Property Organization (WIPO)0193933► Subscribe
Australia6680601► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Mallinckrodt
Colorcon
Harvard Business School
Chinese Patent Office
US Army
Healthtrust
Fish and Richardson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot